DOV 121167
Latest Information Update: 17 Nov 2007
Price :
$50 *
At a glance
- Originator DOV Pharmaceutical
- Class Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Stress incontinence
Most Recent Events
- 27 Mar 2006 No development reported - Preclinical for Stress incontinence in USA (unspecified route)
- 10 Feb 2004 Preclinical trials in Stress incontinence in USA (unspecified route)